Skip to main content

Table 1 Clinical characteristics of patients

From: Chronically reduced IL-10 plasma levels are associated with hippocampal sclerosis in temporal lobe epilepsy patients

 TLE + HSTLE-HSXLEIGE
n341059536
Female21 (61.8)48 (45.7)49 (51.6)22 (61.1)
Age, years45.1 (13.4)40.6 (13.9)37.0 (14.2)30.7 (12.1)
Age at onset, years12.9 (9.5)18.7 (13.1)16.2 (15.5)13.9 (7.0)
Known remote symptomatic aetiology
 Known aetiology34 (100)60 (57.1)57 (60.0)0
 Genetic00036 (100)
 Duration of epilepsy, years32.1 (14.9)22.4 (16.9)20.8 (14.3)16.6 (11.8)
 Patients who fulfilled the criteria for refractory epilepsy32 (94.1)89 (84.8)83 (87.4)28 (77.8)
 Seizure-free patients for 1 year before labs3 (8.8)17 (16.1)15 (15.7)15 (41.6)
 At least one seizure 1 month before labs25 (73.5)69 (65.7)60 (63.2)14 (38.9)
 Seizure frequency 1 month before labs2.9 (2.9)4.7 (10.0)7.7 (15.0)0.8 (1.4)
 Autoimmune disease5 (14.7)10 (9.5)6 (6.3)2 (5.6)
Surgery
 No surgery26 (76.5)84 (80.0)82 (86.3)36
 Epilepsy surgery8 (23.5)11 (10.5)2 (2.1)0
 Other lesional surgery010 (9.5)11 (11.5)0
  1. Presented as the mean and standard deviation (for age, age at onset and the duration of epilepsy) or the frequency and proportion (for the rest of the variables)
  2. TLE + HS Temporal lobe epilepsy with hippocampal sclerosis, TLE-HS Temporal lobe epilepsy without hippocampal sclerosis, XLE Extra-temporal lobe epilepsy, IGE Idiopathic generalized epilepsy